PARP Inhibitors in the Management of Ovarian Cancer: ASCO Living Guideline, Version 2026.1.0

William P. Tew, Christina Lacchetti, Tracey Sheridan Adams, Susana Banerjee, Elizabeth V. Connor, Katherine Fuh, Monica B. Jones, Stéphanie Lheureux, Ying L. Liu, Kathleen Maxian, Kathleen Moore, Carolyn Y. Muller, Navya Nair, Clare L. Scott, Anil K. Sood, Kristin Taylor, Oladapo Yeku, Elise C. Kohn

Open source

DOI
10.1200/jco-26-02412
Published
2026-10-27
Container
Journal of Clinical Oncology
Publisher
American Society of Clinical Oncology (ASCO)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/jco-26-02412,
  title = {PARP Inhibitors in the Management of Ovarian Cancer: ASCO Living Guideline, Version 2026.1.0},
  author = {William P. Tew and Christina Lacchetti and Tracey Sheridan Adams and Susana Banerjee and Elizabeth V. Connor and Katherine Fuh and Monica B. Jones and Stéphanie Lheureux and Ying L. Liu and Kathleen Maxian and Kathleen Moore and Carolyn Y. Muller and Navya Nair and Clare L. Scott and Anil K. Sood and Kristin Taylor and Oladapo Yeku and Elise C. Kohn},
  year = {2026},
  journal = {Journal of Clinical Oncology},
  doi = {10.1200/jco-26-02412},
  url = {https://doi.org/10.1200/jco-26-02412}
}

RIS

TY  - JOUR
TI  - PARP Inhibitors in the Management of Ovarian Cancer: ASCO Living Guideline, Version 2026.1.0
AU  - William P. Tew
AU  - Christina Lacchetti
AU  - Tracey Sheridan Adams
AU  - Susana Banerjee
AU  - Elizabeth V. Connor
AU  - Katherine Fuh
AU  - Monica B. Jones
AU  - Stéphanie Lheureux
AU  - Ying L. Liu
AU  - Kathleen Maxian
AU  - Kathleen Moore
AU  - Carolyn Y. Muller
AU  - Navya Nair
AU  - Clare L. Scott
AU  - Anil K. Sood
AU  - Kristin Taylor
AU  - Oladapo Yeku
AU  - Elise C. Kohn
PY  - 2026
JO  - Journal of Clinical Oncology
DO  - 10.1200/jco-26-02412
UR  - https://doi.org/10.1200/jco-26-02412
ER  - 

APA

Tew, W. P., Lacchetti, C., Adams, T. S., Banerjee, S., Connor, E. V., Fuh, K., Jones, M. B., Lheureux, S., Liu, Y. L., Maxian, K., Moore, K., Muller, C. Y., Nair, N., Scott, C. L., Sood, A. K., Taylor, K., Yeku, O., & Kohn, E. C. (2026). PARP Inhibitors in the Management of Ovarian Cancer: ASCO Living Guideline, Version 2026.1.0. Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-02412

Source records